-
Thematic Analysis
NewCircular Economy – Thematic Intelligence
Circular Economy Thematic Report Overview The circular economy seeks to eliminate waste and pollution, keep products and materials in use, and regenerate natural systems. In the traditional linear economy, businesses typically follow a take, make, use, and dispose of the path, with minimal regard for the resources used and the environmental consequences. However, public pressure to mitigate climate change, combat biodiversity loss, and preserve scarce resources is rising. Proactively adopting circular practices can help businesses stay ahead of the evolving...
-
Sector Analysis
NewRadiosurgery Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033
Radiosurgery Systems Market Report Overview The Radiosurgery Systems market size was valued at $618.8 million in 2023 and will grow at a CAGR of more than 3% during 2023-2033. Radiosurgery Systems utilize beams to deliver a focused dose of radiation to a targeted tumor. Radiosurgery Systems Market Outlook 2023-2023 ($ Million) Buy Full Report for More Insights on the Radiosurgery Systems Market Forecast Download a Free Sample Report The Radiosurgery Systems market research report identifies quantitative market trends within cardiovascular...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – IFx-Hu20 in Cutaneous Squamous Cell Carcinoma (cSCC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - IFx-Hu20 in Cutaneous Squamous Cell Carcinoma (cSCC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. IFx-Hu20 in Cutaneous Squamous Cell Carcinoma (cSCC) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EP-0057 in Epithelial Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EP-0057 in Epithelial Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EP-0057 in Epithelial Ovarian Cancer Drug Details: EP-0057 (NLG-207, CRLX-101)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EP-0057 in Small-Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EP-0057 in Small-Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EP-0057 in Small-Cell Lung Cancer Drug Details: EP-0057 (NLG-207, CRLX-101)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EP-0057 in Transitional Cell Carcinoma (Urothelial Cell Carcinoma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EP-0057 in Transitional Cell Carcinoma (Urothelial Cell Carcinoma) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EP-0057 in Transitional Cell Carcinoma (Urothelial Cell...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EP-0057 in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EP-0057 in Metastatic Castration-Resistant Prostate Cancer (mCRPC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EP-0057 in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Drug...
-
Company Insights
NewIgnite Biomedical Inc Pipeline Insight and Competitive Landscape, 2024
Empower your strategies with our Ignite Biomedical Inc Pipeline Insight and Competitive Landscape, 2024 report and make more profitable business decisions. Ignite Biomedical Inc (Ignite Biomedical) discovers algorithm biomarkers that enable the development and commercialization of precision medicine to inform individualized treatment decisions. The company utilizes Emerge, a quantitative artificial intelligence (AI) platform, that analyzes data from complex non-linear systems which produces unbiased and accurate predictive algorithms. It is developing its biomarker blood test pipeline in therapeutic areas of rheumatoid...
-
Product Insights
NewStreck Inc Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Streck Inc Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Streck Inc (Streck) is a developer and manufacturer of hematology, immunology and molecular biology products for clinical and research laboratories. The company provide products such as offers body fluid, sedimentation-rate, chemistry, whole blood, whole blood glucose and hemoglobin, instruments and consumables, antibiotic resistance kits, reagents and thermometers. It also provides laboratory products, blood collection tubes, multi-parameter assayed hematology controls; linearity...
-
Product Insights
NewNeusoft Medical Systems Co Ltd Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Neusoft Medical Systems Co Ltd Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Neusoft Medical Systems Co Ltd (Neusoft Medical), a subsidiary of Neusoft Corp is a medical device company that provides medical equipment and services. The company offers medical imaging equipment, e-hospital solutions, regional medical and personal healthcare products. Its product portfolio includes computed tomography, magnetic resonance imaging products, x-ray, radiotherapy products, ultrasound, positron emission tomography, linear accelerator and...